On September 2, 2021 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported that Raul Rodriguez, the company’s president and chief executive officer, and Dean Schorno, the company’s chief financial officer, will participate in the following virtual investor conferences in September (Press release, Rigel, SEP 2, 2021, View Source [SID1234587176]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual Biopharma Conference (September 8-10, 2021)

Raul Rodriguez will participate in a panel discussion entitled: "Sickle Cell, Beta-Thal, ITP & PKD – Measuring Industry Progress in Benign Hematology" on Friday, September 10th at 12:30 p.m. ET.
H.C. Wainwright 23rd Annual Global Investment Conference (September 13-15, 2021)

Dean Schorno will present a company overview, which will be available for on-demand viewing for conference attendees starting on Monday, September 13th at 7:00 a.m. ET.
Cantor Fitzgerald Global Healthcare Conference (September 27-30, 2021)

Raul Rodriguez will present a company overview on Tuesday, September 28th at 4:40 p.m. ET.
To access the live webcast of the Citi Annual Biopharma Conference panel and the Cantor Fitzgerald Global Healthcare Conference presentation, go to the Investor Relations section of the company’s website at www.rigel.com. Please connect to Rigel’s website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.